Cell cycle regulation and differentiation

Details Cell cycle regulation and differentiation Cell cycle regulation and differentiation

2011-08-09

2011-08-09

Pak, Michael (Department: 1646)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

Reexamination Certificate

active

07993921

ABSTRACT:
The present invention provides compositions and methods for regulating neural cell proliferation or differentiation. The present invention also provides methods for selecting for bioactive agents effective in regulating proliferation or differentiation.

REFERENCES:
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5175385 (1992-12-01), Wagner et al.
patent: 5298422 (1994-03-01), Schwartz et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5484892 (1996-01-01), Tedder et al.
patent: 5585097 (1996-12-01), Bolt et al.
patent: 5631146 (1997-05-01), Szostak et al.
patent: 5691145 (1997-11-01), Pitner et al.
patent: 5756264 (1998-05-01), Schwartz et al.
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5837832 (1998-11-01), Chee et al.
patent: 5846534 (1998-12-01), Waldmann et al.
patent: 6033884 (2000-03-01), Woo et al.
patent: 6465246 (2002-10-01), Mueller et al.
patent: 6491916 (2002-12-01), Bluestone et al.
patent: 6670147 (2003-12-01), Heidtmann et al.
patent: 6839586 (2005-01-01), Webb
patent: 6846625 (2005-01-01), Tally et al.
patent: 6855504 (2005-02-01), Fogarty
patent: 6902881 (2005-06-01), Falchuk
patent: 6962980 (2005-11-01), Mitcham et al.
patent: 6966424 (2005-11-01), Cram
patent: 6972195 (2005-12-01), Xu
patent: 6977733 (2005-12-01), Denk et al.
patent: 6982168 (2006-01-01), Topalian et al.
patent: 6982321 (2006-01-01), Winter
patent: 6998118 (2006-02-01), Kasper et al.
patent: 7008634 (2006-03-01), Cima et al.
patent: 2003/0108548 (2003-06-01), Bluestone et al.
patent: 2004/0006216 (2004-01-01), Waldmann et al.
patent: 2004/0092448 (2004-05-01), Ohta et al.
patent: 2004/0166099 (2004-08-01), Rao
patent: 2004/0265276 (2004-12-01), Perricaudet et al.
patent: 2005/0002906 (2005-01-01), Gregory et al.
patent: 2005/0014166 (2005-01-01), Trono et al.
patent: 2005/0048031 (2005-03-01), Haddada et al.
patent: 2005/0054832 (2005-03-01), Lazar et al.
patent: 2005/0063953 (2005-03-01), Falck-Pedersen et al.
patent: 2005/0101559 (2005-05-01), Lawrence et al.
patent: 2005/0106731 (2005-05-01), Davidson et al.
patent: 2005/0196751 (2005-09-01), Burcin et al.
patent: 2006/0002921 (2006-01-01), Winsor-Hines et al.
patent: WO 92/10092 (1992-06-01), None
patent: WO 93/09668 (1993-05-01), None
patent: WO 93/18759 (1993-09-01), None
patent: WO 97/10365 (1997-03-01), None
patent: WO 97/38731 (1997-10-01), None
U.S. Appl. No. 07/855,389, filed Mar. 20, 1992, Woo, et al.
Adang, et al. The reconstruction and expression of aBacillus thuringiensiscryIIIA gene in protoplasts and potato plants. Plant Molec. Biol. 1993; 21: 1131-1145.
Alheim, et al. Identification of a functional glucocorticoid response element in the promoter of the cyclin-dependent kinase inhibitor p57Kip2. J. Mol. Endocrinol. 2003; 30:359-368.
Appleman, et al. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 2002; 168:2729-2736.
Ausubel, et al. eds. Current Protocols in Molecular Biology. Wiley, John & Sons, Inc 1987 (Table of Contents).
Ausubel, et al. eds. Short Protocols in Molecular Biology. 4th edition. Wiley, John & Sons, Inc 1999 (Table of Contents).
Baas, et al. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia. 1997; 19:324-332.
Baines, et al. “Purification of Immunoglobulin G (IgG)” in Methods In Molecular Biology. The Humana Press, Inc. 1992; 10:79-104.
Balint, et al. Induction of p57(KIP2) expression by p73beta. Proc. Natl. Acad. Sci. USA 2002; 99: 3529-3534.
Bambot, et al. Efficient total gene synthesis of 1.35-kb hybrid alpha-lytic protease gene using the polymerase chain reaction. PCR Methods and Applications. 1993; 2:266-271.
Barres, et al. Control of oligodendrocyte number in the developing rat optic nerve. Neuron. 1994; 12;935-942.
Barres, et al. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 1994; 120:1097-1108.
Barres, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 1992; 70: 31-46.
Barres, et al, Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. May 1993;118(1):283-295.
Baumann, et al. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001; 81: 871-927.
Billon, et al. Roles for p53 and p73 during oligodendrocyte development. Development. 2004; 131:1211-1220.
Bitter, et al. Expression and secretion vectors for yeast. Methods in Enzymol. 1987; 153:516-544.
Boussiotis, et al. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 2000; 6:290-297.
Brody, et al. Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 2000; 74:5-13.
Bruck, et al. Remyelination in multiple sclerosis. J. Neurol. Sci. 2003; 206: 181-185.
Calver, et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron. 1998; 20:869-882.
Casaccia-Bonnefil, et al. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development. 1999; 126;4027-4037.
Chu, et al. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm. Res. 1990; 7:824-834.
Coligan, et al. eds. Current Protocol in Immunology. Wiley, John & Sons, Inc. 1991. (Table of Contents).
Compston, et al. Multiple sclerosis, Lancet. 2002; 359:1221-1231.
Cunningham, et al. Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ. 2001; 12:387-396.
Dillon, et al. Use of the Polymerase Chain Reaction of the Rapid Construction of Synthetic Genes. In Methods In Molecular Biology. The Humana Press, Inc. 1993; 15:263-268.
Dubois-Dalcq, et al. Enhancing central nervous system remyelination in multiple sclerosis. Neuron. 2005; 48:9-12.
Dugas, et al. A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci. Jun. 6, 2007;27(23):6185-6196.
Dugas, et al. Functional genomic analysis of oligodendrocyte differentiation. J. Neurosci. 2006; 26:10967-10983.
Dussault, et al. Thyroid hormones and brain development. Ann. Rev. Physiol. 1987; 49:321-334.
Eglitis, et al. Retroviral vectors for introduction of genes into mammalian cells. BioTechniques. 1988; 6(7):608-614.
Elbashir, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001: 411;494-498.
Elbashir, et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001; 15:188-200.
Eppstein, et al. Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell mem3brane receptor. Proc. Natl. Acad. Sci. USA 1985; 82: 3688-3692.
Flusberg, et al. Fiber-optic fluorescence imaging. Nat. Methods. 2005; 2:941-950.
Freshney, ed. Animal Cell Culture. Wiley, John & Sons, Inc. 1986. (Cover and table of contents pages only).
Gabizon, et al. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. National Cancer Inst. 1989; 81:1484-1488.
Georgia, et al. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev. Biol. 2006; 298:22-31.
Ghiani, et al. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J. Neurosci. 2001; 21:1274-1282.
Gold, et al. Diversity of oligonucleotide functions. Ann. Rev. Biochem, 1995; 64:763-797.
Haller, et al. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc. Natl. Acad. Sci. USA 1997; 94:8521-8526.
Hardy, R. Dorsoventral patterning and oligodendroglia

Affiliated with

Also associated with

Rating

Cell cycle regulation and differentiation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell cycle regulation and differentiation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell cycle regulation and differentiation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2751494